Cav3.2 deletion attenuates nonalcoholic fatty liver disease in mice
Xue Li(Department of Health), Chaoliang Tang(University of Science and Technology of China)
Cited by 0
Related Papers
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
|The Lancet Infectious Diseases|2021|251
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
|Emerging Microbes & Infections|2020|240
Access and Unmet Needs of Orphan Drugs in 194 Countries and 6 Areas: A Global Policy Review With Content Analysis
|Value in Health|2020|109
Palmatine Protects against Cerebral Ischemia/Reperfusion Injury by Activation of the AMPK/Nrf2 Pathway
|Oxidative Medicine and Cellular Longevity|2021|74
Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study
|The Lancet Regional Health - Western Pacific|2022|66